|Position||Trades||Duration||Win rate||Win/loss||Avg win||Avg loss||Return|
|Position||Trades||Duration||Win Rate||Win/Loss||Avg Win||Avg Loss||Return|
Trading: HOLD @ $16.35
Signal Strength: MEDIUM
Resmed (ASX:RMD) current accumulation has given strength to the share price and the continuation of bullish trading conditions. Currently, the ADLINE is 28125.1. day. During the quarter, the highest ADLINE value was 459704.
Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. Indicator can be applied to the short/medium term timeframe, but the best results are obtained with larger cyclical swings in-line with the trend direction. This accumulation / distribution oscillator can provide guidance on the money flow direction from the companies recent trading.
Accumulation/distribution (ADLINE) is a momentum indicator that attempts to gauge supply and demand by determining whether investors are generally accumulating or buying or distributing or selling a certain stock by identifying divergences between stock price and volume flow. The accumulation/distribution is calculated by first calculating the money flow multiplier then multiplying the money flow multiplier by the period’s volume.
Calculation: Accumulation Distribution Line:
1) Money Flow Multiplier = [(close - low) - (high - close)] / (high - low);
2) Money Flow Volume = Money Flow Multiplier x volume for the period;
3) Accumulation/Distribution= previous Accumulation/Distribution + current periods Money Flow Volume.
PROFILE: Resmed (RMD.AX)
Stock Exchange: ASX
Ticker Codes: | RMD.AX | ASX:RMD |
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides humidifiers, carry bags, and breathing circuits; and data communications and control products, such as EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators. It markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 120 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
|MPL Medibank Private||3.21||11.5||23,800,298||2,538,212||BULLISH|
|WBC Westpac Banking Corporation||27.75||9.2||24,404,464||2,513,264.8||BULLISH|
|AHG Advance Healthcare||2.55||9||1,585,387||226,338.2||BULLISH|
|ANZ Australia & Banking||27.86||7.8||14,554,708||1,414,878.6||BULLISH|
|RHC Ramsay Health Care||69.58||7.3||1,172,273||180,042||BULLISH|
|AYS Amaysim Australia||0.76||7||283,622||39,215.2||BULLISH|
|CBA Commonwealth Bank||77.4||6.3||9,829,411||1,089,681.2||BULLISH|
|JBH Jb Hi-Fi||26.92||5.2||559,642||98,791.8||BULLISH|